Bayer Aktie

26,29EUR -0,10EUR -0,38%
Bayer für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: BAY001 / ISIN: DE000BAY0017
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 96,91
Temasek Holdings Pte Ltd. (Investment Management) 3,52
Norges Bank Investment Management 3,15
Amundi Asset Management SA 3,09
Silchester International Investors LLP 3,00
Government Pension Fund - Global (The) 2,06
Dodge & Cox International Stock Fund 1,54
Oakmark International Fund 1,45
Vanguard Total International Stock Index Fund 1,37
Vanguard Developed Markets Index Fund 0,83

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 103 824 99 538 99 637 101 369 99 723
Umsatz pro Mitarbeiter in Mio. EUR 0,42 0,42 0,44 0,50 0,48

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 31 760 35 002 31 994 37 247 37 090
Summe Anlagevermögen 86 308 72 154 73 823 80 235 77 716
Summe Aktiva 131 327 122 850 126 778 130 884 123 344

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 38 971 41 630 40 803 41 462 44 789
Summe Fremdkapital 83 810 92 151 93 610 91 958 90 266
Summe Eigenkapital 47 517 30 699 33 168 38 926 33 078
Summe Passiva 131 327 122 850 126 778 130 884 123 344

Adresse

Kaiser-Wilhelm-Allee 1, 51368 Leverkusen
Telefon +49 (214) 30-1
Internet http://www.bayer.com

Management

Alan Schultz
Head-North America Project Procurement
Alberto Weisser
Independent Member-Supervisory Board
Andrea Sacher
Member-Supervisory Board
André van Broich
Member-Supervisory Board
Barbara Gansewendt
Member-Supervisory Board
Bijoy Sagar
Chief Information Technology Officer
Brad Griffith
Vice President
Christian Rommel
Head-Research & Development
Claudia Schade
Member-Supervisory Board
Colleen A. Goggins
Independent Member-Supervisory Board
Ertharin Cousin
Independent Member-Supervisory Board
Francesco Grioli
Member-Supervisory Board
Frank Löllgen
Member-Supervisory Board
Frank Rittgen
Head-Mergers & Acquisitions
Heike Hausfeld
Vice Chairman-Supervisory Board
Heike Prinz
Member-Management Board
Heiko Willem-Jan Schipper
President-Consumer Health Division
Heinz Georg Webers
Member-Supervisory Board
Horst Heinz Paul Baier
Independent Member-Supervisory Board
Itziar Canamasas
Head-Oncology Europe, Middle East & Africa
Julio Triana
Member-Management Board
Jürgen Eckhardt
Head-Business Development & Licensing
Kimberly Marie Lein-Mathisen
Independent Member-Supervisory Board
Markus Siebenmorgen
Head-Human Resources & Social Services
Michael Westmeier
Member-Supervisory Board
Miriam Holstein
Head-Corporate Office
Norbert W. Bischofberger
Independent Member-Supervisory Board
Norbert Winkeljohann
Chairman-Supervisory Board
Otmar D. Wiestler
Independent Member-Supervisory Board
Paul Achleitner
Member-Supervisory Board
Philipp Blank
Head-Law, Compliance & Information Technology
Rodrigo Santos
President-Crop Science Division
Ruzha Draganova
Global HR Business Partner
Simone Bagel-Trah
Independent Member-Supervisory Board
Stefan Oelrich
President-Pharmaceuticals Division
Thomas Hoffmann
Head-Treasury
Thomas Kornek
Vice President-Investor Relations
William N. Anderson
Chief Executive Officer
Wolfgang U. Nickl
Head-Finance
Yasmin Fahimi
Member-Supervisory Board